180 related articles for article (PubMed ID: 15450775)
1. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.
Cailloux F; Gauthier-Barichard F; Mimault C; Isabelle V; Courtois V; Giraud G; Dastugue B; Boespflug-Tanguy O
Eur J Hum Genet; 2000 Nov; 8(11):837-45. PubMed ID: 11093273
[TBL] [Abstract][Full Text] [Related]
3. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease.
Wolf NI; Sistermans EA; Cundall M; Hobson GM; Davis-Williams AP; Palmer R; Stubbs P; Davies S; Endziniene M; Wu Y; Chong WK; Malcolm S; Surtees R; Garbern JY; Woodward KJ
Brain; 2005 Apr; 128(Pt 4):743-51. PubMed ID: 15689360
[TBL] [Abstract][Full Text] [Related]
4. A severe connatal form of Pelizaeus Merzbacher disease in a Czech boy caused by a novel mutation (725C>A, Ala242Glu) at the 'jimpy(msd) codon' in the PLP gene.
Seeman P; Paderova K; Benes V; Sistermans EA
Int J Mol Med; 2002 Feb; 9(2):125-9. PubMed ID: 11786921
[TBL] [Abstract][Full Text] [Related]
5. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
Inoue K
Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
[TBL] [Abstract][Full Text] [Related]
6. A new polymorphism in the proteolipid protein (PLP1) gene and its use for carrier detection of PLP1 gene duplication in Pelizaeus-Merzbacher disease.
Hobson G; Stabley D; Funanage V; Marks H
Hum Mutat; 2001 Feb; 17(2):152. PubMed ID: 11180600
[TBL] [Abstract][Full Text] [Related]
7. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.
Saugier-Veber P; Munnich A; Bonneau D; Rozet JM; Le Merrer M; Gil R; Boespflug-Tanguy O
Nat Genet; 1994 Mar; 6(3):257-62. PubMed ID: 8012387
[TBL] [Abstract][Full Text] [Related]
8. Novel exon 3B proteolipid protein gene mutation causing late-onset spastic paraplegia type 2 with variable penetrance in female family members.
Sivakumar K; Sambuughin N; Selenge B; Nagle JW; Baasanjav D; Hudson LD; Goldfarb LG
Ann Neurol; 1999 May; 45(5):680-3. PubMed ID: 10319897
[TBL] [Abstract][Full Text] [Related]
9. Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease.
Hübner CA; Orth U; Senning A; Steglich C; Kohlschütter A; Korinthenberg R; Gal A
Hum Mutat; 2005 Mar; 25(3):321-2. PubMed ID: 15712223
[TBL] [Abstract][Full Text] [Related]
10. Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males.
Osaka H; Kawanishi C; Inoue K; Uesugi H; Hiroshi K; Nishiyama K; Yamada Y; Suzuki K; Kimura S; Kosaka K
Biochem Biophys Res Commun; 1995 Oct; 215(3):835-41. PubMed ID: 7488049
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of PLP and its role in the nervous system.
Griffiths I; Klugmann M; Anderson T; Thomson C; Vouyiouklis D; Nave KA
Microsc Res Tech; 1998 Jun; 41(5):344-58. PubMed ID: 9672418
[TBL] [Abstract][Full Text] [Related]
12. [Pelizaeus-Merzbacher disease(PMD)/spastic paraplegia 2(SPG2)].
Eto Y
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):536-7. PubMed ID: 11032015
[No Abstract] [Full Text] [Related]
13. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy.
Shy ME; Hobson G; Jain M; Boespflug-Tanguy O; Garbern J; Sperle K; Li W; Gow A; Rodriguez D; Bertini E; Mancias P; Krajewski K; Lewis R; Kamholz J
Ann Neurol; 2003 Mar; 53(3):354-65. PubMed ID: 12601703
[TBL] [Abstract][Full Text] [Related]
14. Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease.
Hodes ME; Blank CA; Pratt VM; Morales J; Napier J; Dlouhy SR
Am J Med Genet; 1997 Mar; 69(2):121-5. PubMed ID: 9056547
[TBL] [Abstract][Full Text] [Related]
15. Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype.
Plecko B; Stöckler-Ipsiroglu S; Gruber S; Mlynarik V; Moser E; Simbrunner J; Ebner F; Bernert G; Harrer G; Gal A; Prayer D
Neuropediatrics; 2003 Jun; 34(3):127-36. PubMed ID: 12910435
[TBL] [Abstract][Full Text] [Related]
16. [Duplication of the PLP gene and the classical form of Pelizaeus-Merzbacher disease].
Blanco-Barca MO; Eirís-Puñal J; Soler-Regal C; Castro-Gago M
Rev Neurol; 2003 Sep 1-15; 37(5):436-8. PubMed ID: 14533091
[TBL] [Abstract][Full Text] [Related]
17. Family with Pelizaeus-Merzbacher disease/X-linked spastic paraplegia and a nonsense mutation in exon 6 of the proteolipid protein gene.
Bond C; Si X; Crisp M; Wong P; Paulson GW; Boesel CP; Dlouhy SR; Hodes ME
Am J Med Genet; 1997 Aug; 71(3):357-60. PubMed ID: 9268109
[TBL] [Abstract][Full Text] [Related]
18. Clinical and mutational spectrum of Colombian patients with Pelizaeus Merzbacher Disease.
Velasco Parra HM; Maradei Anaya SJ; Acosta Guio JC; Arteaga Diaz CE; Prieto Rivera JC
Colomb Med (Cali); 2018 Jun; 49(2):182-187. PubMed ID: 30104812
[TBL] [Abstract][Full Text] [Related]
19. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene.
Hudson LD
J Child Neurol; 2003 Sep; 18(9):616-24. PubMed ID: 14572140
[TBL] [Abstract][Full Text] [Related]
20. Different mutations in the same codon of the proteolipid protein gene, PLP, may help in correlating genotype with phenotype in Pelizaeus-Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2).
Hodes ME; Zimmerman AW; Aydanian A; Naidu S; Miller NR; Garcia Oller JL; Barker B; Aleck KA; Hurley TD; Dlouhy SR
Am J Med Genet; 1999 Jan; 82(2):132-9. PubMed ID: 9934976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
